SciELO - Scientific Electronic Library Online

vol.11 issue1Universal ethical principles and their application in clinical drug trialsBioethical problems in researching new vaccines: Do they respond to public health reasons? author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Salud colectiva

On-line version ISSN 1851-8265


UGALDE, Antonio  and  HOMEDES, Núria. The impact of researchers loyal to Big Pharma on the ethics and quality of clinical trials in Latin America. Salud colect. [online]. 2015, vol.11, n.1, pp.67-86. ISSN 1851-8265.

This article explains the difficulties innovative pharmaceutical firms have in repaying shareholders with attractive dividends. The problem is the result of the expiration of the patents of blockbuster drugs and the difficulties that the firms have in bringing new blockbuster drugs to the market. One of the solutions companies have found has been to accelerate the implementation of clinical trials in order to expedite the commercialization of new drugs. Doing so increases the period in which they can sell drugs at monopoly prices. We therefore discuss how innovative pharmaceutical firms shorten the implementation time of clinical trials in Latin America and the consequences such actions have on the quality of the collected data, the protection of human rights of the subjects of experimentation, and compliance with the ethical principles approved in international declarations.

Keywords : Clinical Trial; Research Personnel; Ethics Committees; Informed Consent; Ethics; Latin America.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License